Shares of AbbVie Inc. ABBV slipped 1.64% to $170.16 Monday, on what proved to be an all-around dismal trading session for the ...

We recently published a list of Jim Cramer’s Game Plan for Next Week: 25 Stocks in Focus. In this article, we are going to ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

AbbVie Inc. (NYSE:ABBV – Free Report) – Zacks Research reduced their Q1 2025 earnings per share estimates for AbbVie in a research note issued on Tuesday, April 15th. Zacks Research analyst S.

$50,000 of ABBVIE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Education and legislation related to reform of ...

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Should You Invest in AbbVie Inc. (ABBV)? Before you invest in AbbVie Inc. (ABBV), want to know the best stocks to ...